IDH1 and metastatic neoplasm: The attributes associated with an increased risk of death included higher ECOG performance status, larger tumors, metastatic disease at the time of RT, the presence of portal vein thrombus, the presence of satellite lesions, IDH1 mutation, and PIK3CA mutation.